Business Description
SunBio Inc
ISIN : KR7067370007
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.35 | |||||
Equity-to-Asset | 0.59 | |||||
Debt-to-Equity | 0.59 | |||||
Debt-to-EBITDA | 2.57 | |||||
Interest Coverage | 165.29 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 3.71 | |||||
Beneish M-Score | -2.08 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 48.8 | |||||
3-Year EBITDA Growth Rate | 57.7 | |||||
3-Year EPS without NRI Growth Rate | 92.4 | |||||
3-Year Book Growth Rate | 43.8 |
Momentum Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 57.85 | |||||
9-Day RSI | 40.65 | |||||
14-Day RSI | 36.8 | |||||
6-1 Month Momentum % | 10.06 | |||||
12-1 Month Momentum % | -30.13 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.65 | |||||
Quick Ratio | 0.61 | |||||
Cash Ratio | 0.31 | |||||
Days Inventory | 106.45 | |||||
Days Sales Outstanding | 157.04 | |||||
Days Payable | 11.13 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.91 | |||||
Dividend Payout Ratio | 0.2 | |||||
Forward Dividend Yield % | 0.91 | |||||
5-Year Yield-on-Cost % | 0.93 | |||||
3-Year Average Share Buyback Ratio | -2.3 | |||||
Shareholder Yield % | 3.64 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 70.26 | |||||
Operating Margin % | 42.24 | |||||
Net Margin % | 37.48 | |||||
FCF Margin % | -29.62 | |||||
ROE % | 17.74 | |||||
ROA % | 10.31 | |||||
ROIC % | 9.17 | |||||
ROC (Joel Greenblatt) % | 15.5 | |||||
ROCE % | 20.33 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 21.93 | |||||
PE Ratio without NRI | 21.93 | |||||
Shiller PE Ratio | 166.57 | |||||
PEG Ratio | 0.5 | |||||
PS Ratio | 8.22 | |||||
PB Ratio | 3.58 | |||||
Price-to-Tangible-Book | 3.59 | |||||
Price-to-Operating-Cash-Flow | 20.39 | |||||
EV-to-EBIT | 20.43 | |||||
EV-to-EBITDA | 17.44 | |||||
EV-to-Revenue | 9.08 | |||||
EV-to-FCF | -30.12 | |||||
Price-to-Projected-FCF | 32.22 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.88 | |||||
Price-to-Graham-Number | 1.87 | |||||
Earnings Yield (Greenblatt) % | 4.88 | |||||
FCF Yield % | -3.62 |